Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories, 23067-23068 [2017-10241]
Download as PDF
<![CDATA[
23067
Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices
[Docket No. DEA–392]
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 2, 2016, Patheon
Pharmaceuticals, Inc., 2110 E. Galbraith
Road, Cincinnati, Ohio 45237 applied to
be registered as a bulk manufacturer of
gamma hydroxybutyric acid (2010) a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance for
product development.
Bulk Manufacturer of Controlled
Substances Application: Patheon
Pharmaceuticals, Inc.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
21, 2017, Insys Manufacturing, LLC,
2700 Oakmont Drive, Round Rock,
Texas 78665 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
I
I
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for product
development and distribution to its
customers. No other activity for these
drug codes is authorized for this
registration.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–10230 Filed 5–18–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[FR Doc. 2017–10238 Filed 5–18–17; 8:45 am]
ACTION:
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
18, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW 8701
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
18, 2017.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
3, 2017, Eli-Elsohly Laboratories,
Mahmoud A. Elsohly Ph. D., 5
Industrial Park Drive, Oxford,
Mississippi 38655 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: Eli-Elsohly
Laboratories
ACTION:
Notice of application.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Controlled substance
Drug code
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
VerDate Sep<11>2014
19:15 May 18, 2017
Jkt 241001
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
E:\FR\FM\19MYN1.SGM
19MYN1
7350
7360
7370
9145
1100
1105
9041
9050
9120
9143
9150
9180
9193
9300
9333
Schedule
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
23068
Federal Register / Vol. 82, No. 96 / Friday, May 19, 2017 / Notices
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (marihuana) and 7370 (THC) the
company plans to isolate these
controlled substances from procured
7350 (marihuana extract). In reference to
drug code 7360 no cultivation activities
are authorized for this registration. No
other activities for these drug codes are
authorized for this registration.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–10241 Filed 5–18–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: National
Center for Natural Products Research
NIDA MPROJECT
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
18, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
DATES:
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
20, 2017, National Center for Natural
Products Research NIDA MPROJECT,
University of Mississippi, 135 Coy
Waller Complex, P.O. Box 1848,
University, Mississippi 38677–1848
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Drug code
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances to make available to the
National Institute on Drug Abuse
(NIDA) a supply of bulk marihuana for
distribution to research investigators in
support of the national research
program needs. No other activities for
these drug codes are authorized for this
registration.
DEPARTMENT OF JUSTICE
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
DATES:
[FR Doc. 2017–10239 Filed 5–18–17; 8:45 am]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
18, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................
19:15 May 18, 2017
Jkt 241001
PO 00000
Frm 00116
Fmt 4703
Sfmt 4703
I
I
I
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 5,
2016, Chemtos, LLC, 14101 W. Highway
290, Building 2000B, Austin, Texas
78737–9331 applied to be registered as
a bulk manufacturer for the following
basic classes of controlled substances:
Controlled substance
VerDate Sep<11>2014
7350
7360
7370
Schedule
E:\FR\FM\19MYN1.SGM
19MYN1
1248
2565
6250
7011
Schedule
I
I
I
I
]]>Agencies
[Federal Register Volume 82, Number 96 (Friday, May 19, 2017)]
[Notices]
[Pages 23067-23068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10241]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before July 18, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
3, 2017, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph. D., 5
Industrial Park Drive, Oxford, Mississippi 38655 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana Extract.................. 7350 I
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Dihydromorphine.................... 9145 I
Amphetamine........................ 1100 II
Methamphetamine.................... 1105 II
Cocaine............................ 9041 II
Codeine............................ 9050 II
Dihydrocodeine..................... 9120 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Ecgonine........................... 9180 II
Hydrocodone........................ 9193 II
Morphine........................... 9300 II
Thebaine........................... 9333 II
------------------------------------------------------------------------
[[Page 23068]]
The company plans to manufacture the listed controlled substances
for product development and reference standards. In reference to drug
codes 7360 (marihuana) and 7370 (THC) the company plans to isolate
these controlled substances from procured 7350 (marihuana extract). In
reference to drug code 7360 no cultivation activities are authorized
for this registration. No other activities for these drug codes are
authorized for this registration.
Dated: May 15, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-10241 Filed 5-18-17; 8:45 am]
BILLING CODE P
